Search Results - "Kalechman, Y"

Refine Results
  1. 1

    The tellurium‐based immunomodulator, AS101 ameliorates adjuvant‐induced arthritis in rats by Halpert, G., Halperin Sheinfeld, M., Monteran, L., Sharif, K., Volkov, A., Nadler, R., Schlesinger, A., Barshak, I., Kalechman, Y., Blank, M., Shoenfeld, Y., Amital, H.

    Published in Clinical and experimental immunology (01-03-2021)
    “…We report an anti‐rheumatic/inflammatory activity of the non‐toxic, tellurium‐based immunomodulatory compound AS101 in experimental RA by reducing disease…”
    Get full text
    Journal Article
  2. 2

    Modulation of the IL‐2 production defect in vitro in Graves’disease by EISENSTEIN, Z., ENGELSMAN, E., WEISS, M., KALECHMAN, Y., SREDNI, B.

    Published in Clinical and experimental immunology (28-06-2008)
    “…SUMMARY IL‐2 production by mitogen‐induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including…”
    Get full text
    Journal Article
  3. 3

    Tellurium Compound AS101 Induces PC12 Differentiation and Rescues the Neurons from Apoptotic Death by MAKAROVSKY, D, KALECHMAN, Y, SONINO, T, FREIDKIN, I, TEITZ, S, ALBECK, M, WEIL, M, GEFFEN-ARICHA, R, YADID, G, SREDNI, B

    Published in Annals of the New York Academy of Sciences (01-12-2003)
    “…: Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra (SN). Studies show that anti‐apoptotic and neurotrophic…”
    Get full text
    Journal Article
  4. 4

    Role of Endogenous Cytokines Secretion in Radioprotection Conferred by the Immunomodulator Ammonium Trichloro(dioxyethylene-0-0')tellurate by Kalechman, Y., Zuloff, A., Albeck, M., Strassmann, G., Sredni, B.

    Published in Blood (15-03-1995)
    “…The immunomodulator ammonium trichloroldioxyethylene-0-0'Itellurate (AS101) has previously been found by us to have radioprotective properties when injected…”
    Get full text
    Journal Article
  5. 5

    Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide by Sredni, B, Albeck, M, Tichler, T, Shani, A, Shapira, J, Bruderman, I, Catane, R, Kaufman, B, Kalechman, Y

    Published in Journal of clinical oncology (01-09-1995)
    “…The aim of this study was to evaluate the ability of the immunomodulator AS101 to prevent chemotherapy-induced neutropenia and thrombocytopenia and thus allow…”
    Get more information
    Journal Article
  6. 6

    Induction of a subpopulation of suppressor cells by a single blood transfusion by Gafter, Uzi, Kalechman, Yona, Sredni, Benjamin

    Published in Kidney international (01-01-1992)
    “…Induction of a subpopulation of suppressor cells by a single blood transfusion. Blood transfusion induces immunosuppression by a mechanism which is probably…”
    Get full text
    Journal Article
  7. 7

    A new immunomodulating compound (AS-101) with potential therapeutic application by Sredni, B, Caspi, R. R, Klein, A, Kalechman, Y, Danziger, Y, BenYa'akov, M, Tamari, T, Shalit, F, Albeck, M

    Published in Nature (London) (12-11-1987)
    “…There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action. Direct administration of…”
    Get full text
    Journal Article
  8. 8

    Tubulointerstitial nephritis and uveitis: association with suppressed cellular immunity by Gafter, U, Kalechman, Y, Zevin, D, Korzets, A, Livni, E, Klein, T, Sredni, B, Levi, J

    “…It is suggested that tubulointerstitial nephritis and uveitis (TINU) is a cell-mediated immune disease with a favourable response to treatment with steroids…”
    Get more information
    Journal Article
  9. 9

    The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma by Kalechman, Y, Shani, A, Dovrat, S, Whisnant, JK, Mettinger, K, Albeck, M, Sredni, B

    Published in The Journal of immunology (1950) (01-02-1996)
    “…The immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate (AS101) has been shown to possess antitumoral properties in several murine models. In the…”
    Get full text
    Journal Article
  10. 10

    The effect of a single whole-blood transfusion on cytokine secretion by KALECHMAN, Y, GAFTER, U, SOBELMAN, D, SREDNI, B

    Published in Journal of clinical immunology (01-03-1990)
    “…The effect of a single whole-blood transfusion on the cascade of cytokine secretion was studied in patients with chronic renal failure. The results indicate…”
    Get full text
    Journal Article
  11. 11

    Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice by Kalechman, Y, Rushkin, G, Nerubay, J, Albeck, M, Sredni, B

    Published in Experimental hematology (01-12-1995)
    “…The immunomodulator AS101 has previously been found to induce mouse and human hematopoietic cells to secrete cytokines such as interleukin-1 alpha (IL-1…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin by Kalechman, Y, Albeck, M, Sredni, B

    Published in Cellular immunology (01-08-1992)
    “…The immunomodulator AS101 has recently been found to have radioprotective properties when injected prior to sublethal and lethal doses of irradiation. In…”
    Get more information
    Journal Article
  15. 15

    Modulation of the IL-2 production defect in vitro in Grave's disease by EISENSTEIN, Z, ENGELSMAN, E, WEISS, M, KALECHMAN, Y, SREDNI, B

    Published in Clinical and experimental immunology (01-05-1994)
    “…IL-2 production by mitogen-induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including Graves' disease…”
    Get full text
    Journal Article
  16. 16

    Synergism between AS101 and PMA in lymphokine production by SREDNI, B, KALECHMAN, Y, SHALIT, F, ALBECK, M

    Published in Immunology (1990)
    “…AS101 [ammonium trichloro (dioxyethylene-o-o') tellurate] has been reported to stimulate normal mouse and human lymphoid cells to proliferate and to produce…”
    Get full text
    Journal Article
  17. 17

    The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment by Kalechman, Y, Sotnik-Barkai, I, Albeck, M, Sredni, B

    Published in Experimental hematology (01-12-1992)
    “…AS101 (ammonium trichloro[dioxyethylene-O-O']tellurate) is a new synthetic compound previously described by us as having immunomodulating properties and…”
    Get more information
    Journal Article
  18. 18

    Radioprotective effects of the immunomodulator AS101 by Kalechman, Y, Albeck, M, Oron, M, Sobelman, D, Gurwith, M, Seghal, SN, Sredni, B

    Published in The Journal of immunology (1950) (01-09-1990)
    “…Ammonium trichloro(dioxyethylene-O-O')tellurate (AS101) is a new synthetic compound previously described by us as having immunomodulating properties and…”
    Get full text
    Journal Article
  19. 19

    Mechanism of radioprotection conferred by the immunomodulator AS101 by Kalechman, Y, Gafter, U, Barkai, I S, Albeck, M, Sredni, B

    Published in Experimental hematology (01-01-1993)
    “…AS101 [ammonium trichloro (dioxyethylene-0-0') tellurate] is a new synthetic compound previously described by us as having immunomodulating properties and…”
    Get more information
    Journal Article
  20. 20

    Generation of T cell lines with suppressive activity derived from autorosette-forming cells of patients with autoimmune diseases by Kalechman, Y, Michlin, H, Gafter, U, Sredni, B

    Published in Annals of the New York Academy of Sciences (01-07-1991)
    “…A unique subpopulation of human suppressor autorosette-forming T cells was fractionated from peripheral blood of healthy donors and patients with various…”
    Get more information
    Journal Article